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Evaluation of portal blood flow in schistosomal
patients: a comparative study between magnetic
resonance imaging and Doppler ultrasonography*
Avaliação do volume de fluxo portal em pacientes esquistossomóticos: estudo
comparativo entre ressonância magnética e ultrassom Doppler
Alberto Ribeiro de Souza Leão1, Danilo Moulin Sales1, José Eduardo Mourão Santos2,
Edson Nakano1, David Carlos Shigueoka3, Giuseppe D’Ippolito4
OBJECTIVE: To evaluate the agreement between Doppler ultrasonography and magnetic resonance imaging
as well as the interobserver reproducibility of both methods in the measurement of portal blood flow in
schistosomal patients. MATERIALS AND METHODS: A cross-sectional, observational, self-paired study
evaluated 21 patients with schistosomiasis mansoni submitted to measurement of portal blood flow with
phase-contrast magnetic resonance imaging and Doppler ultrasonography. RESULTS: A poor intermethod
agreement was observed (intraclass correlation coefficient: 34.5% [CI 95%]). On the other hand, the
interobserver reproducibility was excellent in the evaluation by magnetic resonance imaging (intraclass
correlation coefficient: 99.2% [CI 95%] / Pearson’s correlation coefficient: 99.2% / portal blood flow =
0.806) and by Doppler ultrasonography (intraclass correlation coefficient: 80.6 to 93.0% [CI 95%] / Pearson’s
correlation coefficient: 81.6% to 92.7% / portal blood flow = 0.954, 0.758 and 0.749). CONCLUSION:
There is a poor intermethod agreement in the measurement of portal blood flow. Nevertheless, contrast-
phase magnetic resonance imaging and Doppler ultrasonography demonstrated to be reproducible methods
presenting excellent interobserver agreement in the quantification of portal blood flow in patients with
hepatosplenic schistosomiasis-related portal hypertension.
Keywords: Portal blood flow; Magnetic resonance imaging; Doppler ultrasonography; Reproducibility; Portal
hypertension.
OBJETIVO: Avaliar a concordância entre o ultrassom Doppler e a ressonância magnética e a reprodutibilidade
interobservador desses métodos na quantificação do volume de fluxo portal em indivíduos esquistossomó-
ticos. MATERIAIS E MÉTODOS: Foi realizado estudo transversal, observacional e autopareado, avaliando
21 pacientes portadores de esquistossomose hepatoesplênica submetidos a mensuração do fluxo portal por
meio de ressonância magnética (utilizando-se a técnica phase-contrast) e ultrassom Doppler. RESULTADOS:
Observou-se baixa concordância entre os métodos (coeficiente de correlação intraclasse: 34,5% [IC a 95%]).
A reprodutibilidade interobservador na avaliação pela ressonância magnética (coeficiente de correlação in-
traclasse: 99,2% [IC a 95%] / coeficiente de correlação de Pearson: 99,2% / média do fluxo portal = 0,806)
e pelo ultrassom Doppler (coeficiente de correlação intraclasse: 80,6% a 93,0% [IC a 95%] / coeficiente de
correlação de Pearson: 81,6% a 92,7% / média do fluxo portal = 0,954, 0,758 e 0,749) foi excelente.
CONCLUSÃO: Há uma baixa concordância entre o ultrassom Doppler e a ressonância magnética na mensu-
ração do volume de fluxo na veia porta. A ressonância magnética e o ultrassom Doppler são métodos repro-
dutíveis na quantificação do fluxo portal em pacientes portadores de hipertensão porta de origem esquistos-
somótica, apresentando boa concordância interobservador.
Unitermos: Fluxo portal; Imagem por ressonância magnética; Ultrassonografia Doppler; Reprodutibilidade;
Hipertensão portal.
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INTRODUCTION
In healthy patients, portal hepatic circu-
lation can accommodate great variations in
blood flow with small changes in portal
pressure(1). The main hemodynamic alter-
ations of this system are a chronic increase
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in venous pressure in the portal territory,
defined as portal hypertension. This is usu-
ally secondary to splenic venous blood
flow interference, and clinically translates
into collateral circulation, visible as ab-
dominal wall collaterals, ascites, and eso-
phagogastric alterations, specifically eso-
phageal varices, gastric varices, and con-
gestive gastropathy(1,2). The gradient of
portal pressure is the difference between
the pressure in the inferior vena cava and
the portal vein, and has a normal value of
< 6 mmHg. When it increases above 10–12
mmHg, portal hypertension complications
may occur(3).
Disorders that may progress to portal
system hypertension includes cirrhosis, and
the hepatosplenic form of infection by
Schistosoma mansoni, along with hepatic,
biliary tract, or pancreatic neoplasms.
Thromboembolic events in the portal vein,
and suprahepatic disorders such as right
heart failure or inferior vena cava occlusion
by thrombi or tumors can also contribute(4).
Upper digestive tract hemorrhage caused
by esophagogastric varices is the main com-
plication of portal hypertension in both cir-
rhotic and schistosomal patients, and has
high morbimortality indices(5). The bleed-
ing is a consequence of a chain of events,
beginning with an increase in portal pres-
sure, and progressing to the development
and progressive dilation of gastroesoph-
ageal varices(6). Portal hypertension affects
between 2% and 7% of patients with schis-
tosomiasis, and is the main cause of diges-
tive hemorrhages(7). The incidence of eso-
phageal varices is approximately 85% in
these patients, and progresses to bleeding
in about two-thirds of all cases(8). The
mortality rate at the first bleeding episode
is 11.7%(8).
The diagnosis of portal hypertension
can be made by noninvasive methods,
which include semiological data and
complementary methods, and also by inva-
sive methods including a direct approach
of surgical measurement of the pressure in
the portal system, or indirect methods that
measure the wedged and free hepatic
venous pressures, obtaining a hepatic
venous pressure gradient between these
two pressures(9). The direct measurement of
portal pressure is the most accurate for
evaluating its actual increase(9). The mea-
surement of portal pressure levels may aid
in the differential diagnosis of portal hyper-
tension causes; in the evaluation of bleed-
ing risk due to gastroesophageal varices
rupture, which is the main cause of morbi-
mortality; in the assessment of drug therapy
efficacy; in prophylaxis of gastroesoph-
ageal varices bleeding; in therapeutic de-
cisions in cases of hepatic resection; and in
the evaluation of disease prognosis(5,9).
In spite of the unquestionable advan-
tages of pressure gradient measurement,
this method is invasive and not widely
available because of its high cost and op-
erator-dependence. Therefore, the chal-
lenge of identifying a noninvasive marker
for portal hypertension remains. Several
authors have suggested that some param-
eters of Doppler ultrasonography (DUS)
might be of prognostic value, and may be
useful in assessing the risk of esophageal
varices bleeding. However, the technique
is not often used for this purpose, and its
clinical usefulness is under debate(9).
Noninvasive measurement of portal
vein flow volume in patients with portal
hypertension has gained acceptance as an
alternative method for diagnosis and fol-
low-up. Magnetic resonance imaging (MRI)
is gaining acceptance as a noninvasive
imaging method for evaluating hemody-
namic parameters, including diagnostic
approach and follow-up of patients with
portal hypertension, including those cases
of schistosomal origin.
The high reproducibility of MRI for the
evaluation of hepatic and splenic morphol-
ogy in chronic schistosomal patients(10),
and its role in the diagnostic differentiation
of cirrhotic hepatopathy of alcoholic and
viral origins, has been established(11,12). MRI
has also been demonstrated as a reliable
method for portal flow quantification in
healthy patients, with better interobserver
agreement than DUS, although the inter-
method agreement for the quantification of
portal flow is poor(13). The same reproduc-
ibility indices were observed in evaluating
findings for periportal fibrosis, making
MRI a comprehensive and accurate method
in the evaluation of schistosomal patients(14).
Diagnostic accuracy is a fundamental
parameter for the usefulness of a diagnos-
tic method, and this accuracy can be deter-
mined by measuring its reproducibility or
interobserver agreement(15). This is neces-
sary for validating noninvasive methods
capable of evaluating hemodynamic pa-
rameters that may be pathologically modi-
fied in patients with portal hypertension.
Therefore, patients with hepatosplenic
schistosomiasis have been studied as a
model for the evaluation of portal hyperten-
sion(11,12).
The objective of this study was to evalu-
ate the agreement between DUS and MRI,
and the interobserver reproducibility of
DUS and MRI for the quantification of
portal flow volume in schistosomal pa-
tients.
MATERIALS AND METHODS
A prospective, cross-sectional, observa-
tional, double-blinded, and self-paired
study was conducted from February 2005
to July 2007 on 21 patients (9 men and 12
women) ranging from 23–57 years (mean
age, 40.9 years). This study was approved
by the Institution’s Committee for Ethics in
Research. Exams were performed at a maxi-
mum interval of 15 days, and were prefer-
ably conducted on the same day.
Inclusion criteria were over 18 years old
and Schistosoma mansoni infection diag-
nosis by rectal biopsy or strong clinical and
laboratory evidence (signs of portal hyper-
tension and/or positive stool ova and para-
site exam) with positive epidemiological
evidence (contact with pond or river water
in endemic areas). Exclusion criteria were:
contraindication for MRI (cardiac pace-
maker, cochlear implant, claustrophobia,
presence of cerebral aneurysm clips, allergy
to paramagnetic contrast medium); history
of alcoholism (ingestion of > 160 g of etha-
nol per week); positive serology for B or
C hepatitis virus; history of proven au-
toimmune disorder that might progress as
autoimmune hepatitis; splenectomized pa-
tients; irregular use of beta-blocker drugs
(propranolol), so measurements would be
made under drug influence; or total portal
vein occlusion (total portal thrombosis).
Cases of partial occlusion were not ex-
cluded, as cross-sectional areas of the ves-
sel could be defined without compromis-
ing the portal flow volume measurement.
MRI studies were performed with a
Magnetom Sonata (Siemens; Erlangen,
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Germany) operating with a high magnetic
field (1.5 T), a gradient of 40 mT/m, and a
body coil for signal transmission/reception
(phased array coil). DUS studies were per-
formed with an EnVisor (Philips Medical
Systems; Bothell, WA, USA), using a con-
vex, multi-frequency transducer, following
section planes standardized by the World
Health Organization for sonographic evalu-
ation of the liver, spleen, and splanchnic
vascular system in schistosomal patients(16).
Patients were evaluated after fasting for 6–
8 hours for both imaging methods.
For MRI studies, the patients were in
dorsal decubitus position, with arms el-
evated above the head. To localize the por-
tal vein, true fast imaging with steady pre-
cession sequences (TRUFI: TrueFISP) was
performed in the coronal plane. The phase-
contrast technique was used to measure
portal flow. The technical parameters of the
sequences are in Table 1.
The imaging plane for flow mapping
was perpendicularly adjusted to the middle
segment of the portal vein (Figure 1). The
time required for imaging ranged from 15
to 25 minutes. After exams, images were
independently evaluated by two observers
using a Leonardo (Siemens; Erlangen,
Germany) workstation, with Argus soft-
ware, for flow measurement and hemody-
namic MRI studies (Figure 2). The acquired
images package was manipulated so the
perimeter for the section of the vessel was
manually defined, and characterized by an
area of higher signal intensity, with mean
values of flow volume in the vessel, peak
systolic velocity, mean velocity and section
area supplied by the software.
Doppler study of the portal vein was
performed with the patient in the dorsal
decubitus position after a short rest, with
oblique, subcostal and intercostal sections
of the portal vein trunk at half-the-distance
from its bifurcation, in a similar respiratory
phase and with an insonation angle be-
tween 45° and 60° (Figure 3). Imaging took
20 to 30 minutes. The diameter of the por-
tal vein was measured using calipers, in the
same region where dopplefluxometric sam-
pling was obtained for flow calculation.
The selected interval of the spectral curve
for analysis was at least four seconds. Af-
ter entering required parameters, flow vol-
umes were obtained. Calculations were
TRUFI, true fast imaging with steady precession; TR, repetition time; TE, echo time; ECG, electrocardiogram;
VENC, velocity-encoded cine.
Table 1 MRI sequence technical parameters for portal flow measurement.
Sequence
TR (ms)
TE (ms)
Flip angle (°)
Number of excitations
2D/3D
Slice thickness (mm)
Spacing between slices
Field of view
Number of slices
Orientation
Acquisition time (s)
Phase/frequency
Rectangular field of view
Fat saturation
Pre-saturation
Partial Fourier
Coil
Number of measurements/repetitions
ECG trigger circuit
Respiratory compensation
Order (K space coverage)
Trigger
Echo train length
Bandwidth (Hz/pixel – frequency)
Breath hold
VENC (cm/s)
Flow direction
TRUFI
3.76
1.88
74
1
2D
5
0.5
350
30
Coronal
16
200/256
No
No
No
No
Phased-array
body coil
1
No
No
Standard
Multiple
Fast
501
Yes
Cine phase-contrast 2D
Magnetization
42
12
30
1
2D
6
1.2
350
1
Oblique
105
192/256
No
No
No
No
Phased-array
body coil
1
Yes
No
Standard
Multiple
Fast
105
No
Portal flow
quantification
40
9.7
30
1
2D
5
0.5
28
1
Oblique
233
256/256
No
No
No
No
Phased-array
body coil
1
Yes
No
Standard
Multiple
Fast
105
No
40
Trough plane
Figure 1. Coronal section
plane of the abdomen ac-
quired with the TRUFI se-
quence, used to define the
middle segment of the por-
tal vein.
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Figure 2 Images of the Leonardo workstation, which was used for the Argus software dedicated to the measurement of flow and MRI hemodynamic studies.
based on Doppler spectral mapping and
were automatically performed by the equip-
ment (operator-independent)(17).
DUS imaging was performed and inter-
preted by three independent observers (ob-
servers 1, 2 and 3), with at least three years
of experience in abdominal DUS after medi-
cal residency in imaging diagnosis. MRI
studies were interpreted by two indepen-
dent observers (observers 3 and 4, one with
experience analyzing both methods), with
at least five years of experience in abdomi-
nal MRI. For both methods, specific train-
ing for the measurement of portal flow was
provided, with all observers agreeing upon
the data collection methodology.
Four statistical tools were used: Bland-
Altman plots, paired t-tests, scatter-plots of
the two measurements, and intraclass cor-
relation coefficient (ICC) with a confi-
dence interval (CI) of 95%. When com-
bined, these tools offer complementary and
useful information for analyzing inter-
method reproducibility and interobserver
agreement. The classification proposed by
Fleiss (1981) was used for ICC interpreta-
tion (Table 2).
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of the disease. An increase in pressoric lev-
els promotes an increase in varices size, and
in tension on the vessels walls, causing
bleeding that is associated with high
morbimortality. Thus, the management of
pressoric levels in the portal vein is essen-
tial(18). Recently, the management of hemo-
dynamic parameters that reflect physio-
pathological changes that lead to bleeding
has attracted interest. For example, no
bleeding was found with portal vein
pressoric levels < 12 mmHg(19).
The most accurate technique for evalu-
ating the severity of portal hypertension is
catheterization of one of the hepatic veins,
and measurement of the pressure at this
point and at a free position. The hepatic
venous pressure gradient is calculated as
the difference between the pressure values.
However, this is an expensive procedure
with risks, particularly for patients a with
limited life expectancy, such as patients
with portal hypertension(20).
Consolidating alternatives to invasive
techniques for measuring portal pressure
for diagnostic purposes, including endo-
scopic screening of gastroesophageal va-
rices to prevent the risk of upper digestive
bleeding, is a constant objective for im-
proving the treatment of patients with por-
tal hypertension(21). Currently, DUS is con-
sidered the method of choice for evaluat-
ing portal hypertension, because of its wide
availability and low cost. However, DUS
is susceptible to errors in measuring the
cross-sectional area of vessel, depending of
intra- and interobserver variability, certain
physiological events and biotypes of pa-
tients(22–27).
In healthy individuals, flow velocity is
usually ≥ 15 cm/s. In some studies, varia-
tion can be greater, with values ranging
from 12 to 20 cm/s, and measurements
higher than the upper threshold may be
identified in healthy individuals. In cir-
rhotic patients, values usually range be-
tween 8–13 cm/s(22). In patients with
hepatosplenic schistosomiasis, portal
blood flow velocity values are usually
within normal limits(22).
Recently, MRI techniques have been
used as noninvasive evaluation of the
splanchnic venous system, and measure-
ment of respective hemodynamic param-
eters, especially in follow-up of patients
Figure 3 Spectral curve, with sample acquired by DUS, at the mid-point between the portal vein origin
and bifurcation with an insonation angle of 60°.
Table 2 Categorization of intraclass correlation
coefficients.
Intraclass correlation
coefficient
< 0.40
0.40–0.75
0.75–1.00
Agreement
Poor
Regular
Excellent
Table 3 Summary of intraclass and Pearson correlation coefficients for interobserver and intermethod
agreement.
Interobserver agreement
DUS × MRI
Observers 3 and 4 MRI
Observers 1 and 2 DUS
Observers 1 and 3 DUS
Observers 2 and 3 DUS
Intraclass correlation
coefficient (CI 95%)
34.5% [0.0%; 72.6%]
99.2% [98.5%; 99.9%]
93.0% [87.1%; 98.3%]
80.6% [65.3%; 95.8%]
87.1% [76.6%; 97.5%]
Pearson coefficient
(CI 95%)
33.2% [–11.6%; 66.8%]
99.2% [98.0%; 99.7%]
92.7% [82.6%; 97.0%]
81.6% [59.3%; 92.3%]
89.0% [74.4%; 95.5%]
A statistical significance of 5% (α =
0.05) was adopted for all statistical analy-
ses, with p-values < 5% (p < 0.05) consid-
ered significant. Statistical analysis was
performed with SPSS 12.0 and MedCalc
version 9.4.2.0 softwares.
RESULTS
Poor agreement between MRI and DUS
(intermethod agreement) was observed.
Nonetheless, interobserver reproducibility
was excellent for magnetic resonance im-
aging evaluation and for Doppler ultra-
sonography, according to the results of all
four observers. Correlation and Pearson
coefficients for intermethod and interob-
server correlation are in Table 3.
Based on the results of portal flow vol-
ume for the 21 schistosomal patients, the
mean, median, and CI were calculated for
each method. For DUS, the mean flow
value ranged from 0.966 to 0.986 l/min
with a median from 0.910 to 1.010 l/min,
and a standard deviation between 0.464
and 0.590 l/min. For phase-contrast MRI,
mean flow values ranged from 0.933 to
0.937 l/min with a median from 0.842 to
0.862 L/min, and a standard deviation be-
tween 0.570 and 0.575 l/min.
DISCUSSION
Portal hypertension leads to complica-
tions that tend to progress with the course
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with portal hypertension(28). Studies using
previously calibrated phantoms that simu-
late the physiological conditions of the
portal venous system have demonstrated a
high correlation between flow volume val-
ues with phase-contrast MRI(25,26).
The main motivating factors for this
study were the high correlation obtained in
vitro by phase-contrast MRI evaluation of
hemodynamic parameters in phantoms
simulating the portal system. Also, no sys-
tematic study could be found in the medi-
cal literature on using MRI to measure he-
patic and splenic hemodynamic variables
in patients with schistosomiasis. MRI is
useful not only for evaluating hemody-
namic parameters, but also for comprehen-
sive analysis of the abdominal venous sys-
tem in patients with portal hypertension.
Thus, MR angiography has already been
demonstrated as useful for the evaluation
of the collateral circulation that may be
found in many of portal hypertension pa-
tients(23,29). The portal hypertension schis-
tosomal model was selected because of the
wide range and variability of observed flow
volumes, typical of its hemodynamic pat-
tern of portal hyperflow, which made it
suitable for investigating and evaluating
the accuracy of diagnostic methods(5).
The imaging techniques used in this
study are widely available for both MRI
and DUS devices, so this work may be the
basis for other investigations on other
equipments. A poor intermethod agree-
ment was observed. The ICC was 34.5%
(CI 95% = 0.0%, 72.6%). Bland-Altman
plots demonstrated a higher number of
positive differences, i.e., DUS measure-
ments with values higher than those from
MRI.
A plausible explanation for the poor
intermethod agreement in portal vein flow
measurements is the variation in volume as
a function of the respiratory cycle phase.
This parameter is difficult to obtain. In
clinical practice, phase-contrast image ac-
quisition with the breath-holding technique
is not feasible because of the acquisition
time. In these cases image acquisition uses
the free-breathing technique, which is not
used in Doppler ultrasonography. Wolf et
al., in a study evaluating the influence of
the respiratory cycle on variability in phase-
contrast methods that are influenced by
breathing, concluded the possibility of er-
ror, and suggested that the effect in clini-
cal applications could be significant, and
include flow measurement in vessels such
as the inferior vena cava, pulmonary ves-
sels and the portal vein(30).
MRI reproducibility had a high interob-
server agreement. The correlation between
readings was classified as nearly perfect,
with an ICC of 99.2% (CI 95% = 98.5%,
99.9%). These results are consistent with
reports demonstrating a high MRI repro-
ducibility in the evaluation of subjective
and objective parameters(10–14,25–29,31–33).
DUS reproducibility was evaluated at three
different points, and readings from the
three observers were combined in pairs. In
these cases, the results from the three dif-
ferent analyses were very satisfactory, with
a high ICC observed for all situations (r =
0.80, 0.87, 0.93). By paired t-test, observ-
ers were in agreement with the mean value,
and statistical tests did not demonstrate sig-
nificant differences in the acquired mean
flow. A high correlation was seen between
the measurements generated by the observ-
ers. Analysis of interobserver variability for
quantitative variables demonstrated that the
method can be used for objective evalua-
tion of flow variations in patients with
portal hypertension.
This study evaluated MRI and DUS re-
producibility for measurement of mean
portal flow volume, and revealed a good
interobserver agreement. This has never
before been reported for schistosomal pa-
tients. Schistosomiasis is a prevalent dis-
ease in underdeveloped countries. The
wide availability of DUS and the excellent
cost-benefit ratio, as well as evidence of the
good reproducibility of this diagnostic
method reinforce its possibility in
propedeutic and semiological approaches
for patients with portal hypertension.
Limitations in this study include the size
of the sample (21 patients), and the knowl-
edge by the observers that all cases were
schistosomal patients. We could not per-
form direct measurements of hepatic
venous pressure gradients, as this proce-
dure is invasive and not used for routine
clinical treatment in this group of patients.
Thus, a reference standard for gauging the
effectiveness of the portal flow measure-
ments by DUS and MRI was not available.
Therefore, knowing which measurement
method was the most accurate was not
possible, and high intermethod agreement
was not observed. Studies on animal mod-
els are be required to demonstrate the ac-
curacy of such measurements.
In summary, this study demonstrated the
high reproducibility of DUS and phase-
contrast MRI for measurement of portal
vein flow volume in patients with portal
hypertension of schistosomal origin. We
suggest using both methods for the evalu-
ation of such variable. However, the abso-
lute values for portal vein flow volume
obtained by DUS were not comparable to
those acquired by phase-contrast sequence,
and we saw no intermethod agreement,
possibly because of the variability associ-
ated with acquisition using either breath-
holding or free-breathing. Further studies
establishing the physiological and patho-
logical values for portal flow volume for
each method may define the usefulness of
DUS and phase-contrast MRI in diagnos-
tic and prognostic approaches of hemody-
namic portal alterations.
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